Author:
Sharan Mahek,Jha Meenakshi,Chandel Rishima,Syeda Saima,Mathur Runjhun,Jha Niraj Kumar,Jha Saurabh Kumar,Goel Harsh,Shrivastava Anju,Chauhan Sushma,Pamidimarri Sudheer,Jha Abhimanyu Kumar
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Reference35 articles.
1. Ames BN, Gold LS, Willett WS (1995) The causes and prevention of cancer. Proc Natl Acad Sci 92:5258–5256
2. Au Yeung CL, Tsang WP, Tsang TY, Co NN, Yau PL, Kwok TT (2010) HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53. Oncol Rep 24:1599–1604
3. Babar IA, Cheng CJ, Booth CJ, Liang X, Weidhaas JB, Saltzman WM, Slack FJ (2012) Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci USA 109:1695–1704
4. Chen CY, Tsay W, Tang JL, Shen HL, Lin SW, Hyang SY, Yao M, Chen YC, Shen MC, Wang CH, Tien HF (2003) SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia. Genes Chromosomes Cancer 37:300–305
5. Cheng C, Huang C, Ma TT, Bian EB, He Y, Zhang L, Li J (2014) SOCS1 hypermethylation mediated by DNMT1 is associated with lipopolysaccharide-induced inflammatory cytokines in macrophages. Toxicol Lett 225(3):488–497
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献